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The synthesis of a novel 2,2-disubstituted 2H-azirin-3-amine 10 as a building 
block for racemic Glu(2Me) is described. This synthon contains an ester group in the 
side chain. The reaction of 10 with thiobenzoic acid and the amino acid Z-Val-OH 
yielded the racemic monothiodiamide 17, and the dipeptide 18 as a mixture of 
diastereoisomers, respectively (Scheme 2). From 18, each of the protecting groups was 
removed selectively (Scheme 3).
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1. Introduction. – In the last few years we have shown that 2H-azirine-3-amines 
(‘3-amino-2H-azirines’) are versatile synthons for 2,2-disubstituted glycines (α,α-
disubstituded α-amino acids) in peptide synthesis. A useful method for the introduction 
of such amino acids into peptides is the so-called ‘azirine/oxazolone method’ [1], which 
proved to be a convenient preparative access to such peptides. This strategy has been 
applied extensively in the synthesis of linear oligopeptides [2-8], endothiopeptides 
[9-13], conformationally restricted cyclic peptides [14-17], and cyclic depsipeptides 
[17-26] containing 2,2-disubstituted glycines. 
Recently, 2H-azirin-3-amines became available that are enantiomerically pure, 
such as the isovaline (Iva) synthons 1 and 2 [4][27], the Val(2Me), Leu(2Me), and the 
Ala(2cPent) synthons 3, 4, and 5 [27], the Phe(2Me) synthons 6 and 7 [27][28], as well 
as the synthons for Tyr(2Me) 8 and Dopa(2Me) 9 [29]. The latter two contain protected 
phenolic hydroxy groups, and are first examples of enantiomerically pure building 
blocks with a functionalized side chain. All these building blocks can be used for the 
synthesis of stereochemically pure peptides. 
 
Formulae 1 
 
In the present paper, we describe the synthesis of a novel building block 10 for 
Glu(2Me), which contains an ester group as a new functional group in the side chain, 
and its applicability in the synthesis of model peptides. This racemic synthon is a first 
step towards the expansion of our library of enantiomerically pure 2H-azirin-3-amines. 
 
Formula 2 
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2. Results. – 2.1. Synthesis of the 2H-Azirine 10. The 2H-azirin-3-amine 10, i.e. a 
synthon for 2-methylglutamate (Glu(2Me)), was prepared in gram quantity according to 
Scheme 1. 
 
Scheme 1 
 
The synthesis was started from freshly distilled tetrahydro-2H-pyran-2-one (11), 
which is commercially available. Methylation of 11 in α-position to the C=O group by 
deprotonation with lithium diisopropylamide (LDA), followed by treatment with MeI, 
yielded 12. Instead of HMPA, 1,3-dimethylimidazolidin-2-one (DMI), which is of 
lower toxicological risk, was used as an additive [30]. Although Li et al. used 
lithiumhexamethyldisilazanide as a base for similar reactions [30], we preferred LDA in 
the combination with DMI. Therefore, the yield (44%) was lower than reported (70%) 
[31]. 
Hydroxyamide 13 was synthesized directly from 12 by the reaction with N-
methylaniline in the presence of AlCl3 at r.t. Due to its carcinogenic properties, the 
recommended solvent, 1,2-dichlorethane [32], was replaced by CH2Cl2. The yield in 
CH2Cl2 (81%) is only slightly lower than in 1,2-dichlorethane (88%). 
In the next step, the hydroxy group of 13 was oxidized with ruthenium trichloride 
hydrate (RuCl3·H2O) and sodium metaperiodate (NaIO4) to form the carboxylic acid 14. 
This method, in which ruthenium tetroxide (RuO4) is the active species [33], has the 
advantage, that RuCl3·H2O can be used in catalytic amounts, and the stochiometric 
oxidazing agent is NaIO4. The task of NaIO4 is to reoxidize the reduced forms of the 
ruthenium complex to RuO4. As a solvent, a mixture of CCl4, MeCN and H2O in the 
ratio 2 : 2 : 3 was used [34] in a first attempt. As CCl4 is toxic and ecologically 
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undesirable, it was replaced by the same quantity of AcOEt [35]. As a result, the yield 
turned out to be a bit lower (73%) than with CCl4 (84%). 
Methylation of 14 with CH2N2 gave the ester 15 in quantitative yield. The 
synthesis of 10 by the method of Villalgordo and Heimgartner [36][37] was 
unsuccessful, even though 15 is an N-alkyl-N-phenyl amide (Scheme 1). It is assumed 
that deprotonation occurred in α-position to the ester group instead of the α-position to 
the amide group. According to another well established pathway, the amide 15 was first 
converted to the corresponding thioamide 16 with Lawesson reagent in toluene at 130° 
in 93% yield. Finally, the synthesis of 10 was achieved by consecutive treatment of 16 
with 2N COCl2 solution in CH2Cl2, deprotonation with 1,4-diazabicyclo[2.2.2]octane 
(DABCO) in THF, and treatment with NaN3 in THF/DMF, in 90% yield. 
2.2. Reactions of 10 with Thiobenzoic Acid and Z-L-Valine. To demonstrate that 
the new amino-acid synthon 10 shows analogous chemical behavior as the already 
known 2H-azirin-3-amines (cf. [1]), it was reacted with thiobenzoic acid 
[27-29][38][39] (cf. [11][12]) to give the monothiodiamide 17 in 99% yield (Scheme 2). 
The use of 10 as a synthon in peptide synthesis was shown by the reaction with Z-L-
valine (Scheme 2), which led to the dipeptideamide 18 in 96% yield as a mixture of 
diastereoisomers. All attempts to separate the diastereoisomers failed. 
 
Scheme 2 
 
2.3. Selective Cleavage of the Protecting Groups in Dipeptide 18. With the aim of 
proving the usefulness of the described coupling reaction, each of the protecting groups 
of the dipeptide 18 was removed selectively under standard or slightly modified 
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conditions (Scheme 3). For example, the Z group was removed by hydrogenolysis to 
give the N-deprotected dipeptide 19 in quantitative yield. 
 
Scheme 3 
 
By using standard conditions for the hydrolysis of the C-terminal amide group (3N 
HCl in THF/H2O 1 : 1), a mixture of starting material 18 (40%) and the dipeptides 20 
(27%) and 21 (14%) with a deprotected carboxyl group in the side chain and main 
chain, respectively, were obtained. As the cleavage of the methyl ester in the side chain 
occurs so easily, it was assumed that the reaction follows the mechanism presented in 
Scheme 4: Under the reaction conditions, 4H,6H-1,3-oxazepin-7-one 22 could be 
formed instead of the oxazolone 23. Opening of the ring of 22 with H2O to form 20 is 
expected to proceed smoothly. 
 
Scheme 4 
 
Another possibility for the hydrolysis of dipeptide amides is the treatment with 
HCl gas in toluene, followed by hydrolysis with H2O. Thereby, the oxazolone 23 is 
formed as an intermediate (Scheme 3). After treatment of 18 with HCl gas for 13 min in 
toluene at 100°,  oxazolone 23 was isolated in 71% yield after CC. In addition, 22% of 
starting material 18 was recovered, but no acid 21 was obtained. The oxazolone 23 was 
not hydrolized by stirring in H2O at r.t. over night. Only after addition of one drop of 6N 
HCl and stirring at 50° for several hours, the acid 21 was obtained in 71% yield. The 
direct conversion of 18 to 21, without purification of the intermediate oxazolone, gave 
 7 
acid 21 in an overall yield of 70%, and 15% of starting material 18 and 12% of 
oxazolone 23 were isolated from the reaction mixture. 
Finally, the selective hydrolysis of the methyl ester in 18 was achieved under 
standard conditions with LiOH in THF/MeOH/H2O (3 : 1 : 1) in quantitative yield 
(Scheme 3). 
3. Conclusions. – The novel racemic 2,2-disubstituted 2H-azirin-3-amine 10 was 
prepared. This new synthon for α-methylglutamate was successfully reacted with Z-
protected valine and thereby incorporated into a model dipeptide. Each protecting group 
could be removed selectively in good to excellent yield. Therefore, this synthon can 
easily be used in peptide synthesis as a building block for Glu(2Me). The synthesis of 
this racemic synthon is a first step towards the corresponding enantiomerically pure 2H-
azirin-3-amine. 
 
We thank the analytical sections of our institute for NMR and mass spectra and 
for elemental analyses. Financial support of the Swiss National Science Foundation, F. 
Hoffmann-La Roche AG, Basel, the Stiftung für wissenschaftliche Forschung an der 
Universität Zürich, and the Prof. Dr. Hans E. Schmid-Stiftung is gratefully 
acknowledged. 
 
Experimental Part 
1. General. See [27]. IR Spectra: Perkin-Elmer Spectrum one spectrometer. 1H-
NMR (600 MHz) and 13C-NMR (150.9 MHz) Spectra: Bruker AMX-600 instrument. 
2. Preparation of the α-Methylglutamat-Synthon 10. 2.1. 3-Methyloxan-2-one 
(12). A soln. of diisopropylamine (15 ml, 106 mmol) in abs. THF (40 ml) was cooled to 
0°; 1.6M BuLi in hexane (67 ml, 107 mmol) was added, and the mixture was stirred for 
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30 min, cooled to –65°, and freshly distilled tetrahydro-2H-pyran-2-one (11, 10.060 g, 
100 mmol) was added at –65° to –60°. After stirring for 1 h, 1,3-dimethylimidazolidin-
2-one (DMI, 14 ml, 129 mmol) was added at –65°, stirred for 20 min, and MeI (7 ml, 
112 mmol) was added at –65°. After further stirring for 4 h at –65°, the reaction was 
terminated by addition of a very small amount of H2O and AcOH. The org. layer was 
separated, and the aqueous layer was extracted with AcOEt. The combined org. layers 
were dried (Na2SO4) and evaporated. CC (hexane/AcOEt 3 : 2) yielded 4.098 g (44%) 
of 12 as a colorless oil. Rf (hexane/AcOEt 3 : 2) 0.43. IR (neat): 2939m, 1738s, 1462m, 
1380m, 1243m, 1156m, 1117m, 1085m, 1029m, 1014m, 944w, 905w, 752w. 1H-NMR: 
4.40 – 4.25 (m, CH2O); 2.65 – 2.55 (m, MeCH); 2.2 – 2.05 (m, 1 H of MeCHCH2); 1.95 
– 1.85 (m, CH2); 1.6 – 1.5 (m, 1 H of MeCHCH2); 1.24 (d, J = 6.9, Me). 
13C-NMR: 
175.2 (s, CO); 68.3 (t, CH2O); 34.2 (d, CH); 26.7, 21.7 (2t, 2 CH2); 16.3 (q, Me). 
2.2. 5-Hydroxy-N,2-dimethyl-N-phenylpentanamide (13). – 2.2.1. Procedure A. 
To a soln. of AlCl3 (1.124 g, 8.43 mmol, 2 equiv.) in 1,2-dichlorethane (3 ml), N-
methylaniline (1.75 ml, 16.1 mmol, 3.8 equiv.) was added at 15-25° (temperature 
control with ice bath). Thereby, the soln. turned black. 2-Methyloxan-2-one (12, 0.483 
g, 4.23 mmol) in 3 ml 1,2-dichlorethane was added at 15-25°, and the reaction mixture 
was stirred for 5 h. To the grey-brown suspension, 5 ml of H2O were added, and the 
mixture stirred for 30 min. The org. layer was separated, and the aqueous layer was 
extracted with 1,2-dichlorethane and twice with CH2Cl2. The combined org. layers were 
dried (MgSO4), and evaporated. CC (hexane/AcOEt 1 : 1 to AcOEt) yielded 0.822 g 
(88%) of 13. Slightly brown solid. 
2.2.2. Procedure B. To a soln. of AlCl3 (1.134 g, 8.5 mmol, 2 equiv.) in CH2Cl2 (3 
ml), N-methylaniline (1.75 ml, 16.1 mmol, 3.8 equiv.) was added slowly at 15–25° 
(temperature control with ice bath). Thereby, the soln. turned black. 2-Methyloxan-2-
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one (12, 0.489 g, 4.28 mmol) was added at 15-25°, and the reaction mixture was stirred 
for 5 h. To the grey-brown suspension, 5 ml of H2O were added, and the mixture was 
stirred for 30 min and passed through Celite. The layers were separated, and the 
aqueous layer was extracted twice with CH2Cl2. The combined org. layers were dried 
(MgSO4) and evaporated. CC (hexane/AcOEt 1 : 1 to AcOEt) yielded 0.785 g (81%) of 
13. Slightly brown solid. M.p. 68.9 – 69.5°. Rf (CH2Cl2/MeOH 30 : 1) 0.29 – 0.16. IR 
(KBr): 3383s, 2971m, 2946m, 2923m, 2864m, 1637s,1594s, 1495m, 1465m, 1432m, 
1391m, 1370w, 1331w, 1274m, 1227w, 1176w, 1116m, 1067m, 1024w, 986w, 954w, 
909w, 775m, 701s. 1H-NMR: 7.45 – 7.3 (m, 3 arom. H (meta, para)); 7.2 – 7.15 (m, 2 
arom. H (ortho)); 3.55 – 3.5 (m, CH2OH); 3.26 (s, MeN); 2.45 – 2.35 (m, CH); 1.8 – 1.7 
(m, 1 H of CH2); 1.5 – 1.4 (m, CH2); 1.4 – 1.3 (m, 1 H of CH2); 1.04 (d, J = 6.7, Me). 
13C-NMR: 176.7 (s, CO); 144.0 (s, 1 arom. C); 129.7 (d, 2 arom. CH (meta)); 127.7 (d, 
1 arom. CH (para)); 127.3 (d, 2 arom. CH (ortho)); 62.4 (t, CH2OH); 37.3 (q, MeN); 
36.2 (d, CH); 30.6, 30.3 (2t, 2 CH2); 18.3 (q, Me). CI-MS (NH3):  223 (15), 222 (100, 
[M + 1]+), 220 (15), 204 (7, [M – OH]+). Anal. calc. for C13H19NO2 (221.30): C 70.56, 
H 8.65, N 6.33; found: C 70.38, H 8.67, N 6.27. 
2.3. 4-Methyl-5-(N-methyl-N-phenylamino)-5-oxopentanoic acid (14). The 
hydroxyamide 13 (3.21 g, 14.5 mmol) and 12.71 g (59.4 mmol, 4.1 equiv.) of NaIO4 
were solved in a mixture of 24 ml MeCN, 24 ml AcOEt and 36 ml H2O. A small 
amount of RuCl3·H2O was added at r.t. After 4 h, the color of the suspension changed 
from light yellow to brown, which indicated the end of the conversion. H2O was added, 
and the aqueous layer was extracted with AcOEt. The org. layers were combined, dried 
(Na2SO4) and evaporated. Recrystallization from AcOEt/hexane 1 : 1 yielded 2.48 
(73%) of 14. Colorless crystals. M.p. 116.1 – 116.7°. Rf (CH2Cl2/MeOH 10 : 1) 0.34. IR 
(KBr): 3445w, 2961m, 1729s, 1611s, 1586s, 1497m, 1466m, 1454m, 1401m, 1333w, 
 10 
1316w, 1274m, 1260m, 1193s, 1169m, 1115m, 1095w, 1073w, 1046w, 1027w, 1002w, 
976w, 912w, 866w, 796w, 779m, 754w, 716w, 703m. 1H-NMR: 7.45 – 7.3 (m, 3 arom. 
H (meta, para)); 7.2 – 7.15 (m, 2 arom. H (ortho)); 3.26 (s, MeN); 2.5 – 2.45 (m, 
MeCH); 2.35 – 2.2 (m, CH2); 2.0 – 1.9 (m, 1 H of CH2); 1.7 – 1.6 (m, 1 H of CH2); 1.05 
(d, J = 6.8, Me). 13C-NMR: 178.2 (s, CO(acid)); 175.9 (s, CO(amide)); 143.7 (s, 1 arom. 
C); 129.7 (d, 2 arom. CH (meta)); 127.8 (d, 1 arom. CH (para)); 127.2 (d, 2 arom. CH 
(ortho)); 37.4 (q, MeN); 35.6 (d, CH); 31.5, 28.8 (2t, 2 CH2); 17.9 (q, Me). CI-MS 
(NH3):  237 (15), 236 (100, [M + 1]
+). Anal. calc. for C13H17NO3 (235.28): C 66.36, H 
7.28, N 5.95; found: C 66.44, H 7.16, N 5.87. 
2.4. Methyl 4-methyl-5-(N-methyl-N-phenylamino)-5-oxopentanoate (15). To a 
soln. of 14 (2.506 g, 10.65 mmol) in abs. THF (25 ml), 40 ml of a ca. 4N soln. of CH2N2 
in Et2O (prepared according to [40]) were added at 0°, the mixture was stirred until the 
yellow color disappeared. After 40 min, additional CH2N2 soln. (10 ml) was added, and 
the mixture remained yellow. The ice bath was removed, and the mixture was stirred at 
r.t., until the yellow color disappeared again. After addition of another 4 ml of the 
CH2N2 soln., the yellow color remained at r.t. for at least 90 min. Then, the excess of 
CH2N2 was destroyed with AcOH, the solvent was evaporated, and the product was 
dried in HV: 2.696 g (quant.) of 15. Colorless oil. The product was used for the next 
step without further purification. Rf (hexane/AcOEt 2 : 1) 0.31. IR (neat): 2953s, 1738s, 
1653s, 1596s, 1497s, 1436s, 1390s, 1327s, 1268s, 1170s, 1116s, 1074m, 1035m, 
1002m, 987m, 918w, 897w, 842w, 800w, 776m, 752m, 703s. 1H-NMR: 7.45 – 7.35 (m, 
3 arom. H (meta, para)); 7.2 – 7.15 (m, 2 arom. H (ortho)); 3.59 (s, MeO); 3.26 (s, 
MeN); 2.5 – 2.4 (m, CH); 2.35 – 2.15 (m, CH2); 2.0 – 1.9 (m, 1 H of CH2); 1.7 – 1.6 (m, 
1 H of CH2); 1.04 (d, J = 6.7, Me). 
13C-NMR: 175.9 (s, CO(amide)); 173.4 (s, 
CO(ester)); 143.8 (s, arom. C); 129.7 (d, 2 arom. CH (meta)); 127.7 (d, 1 arom. CH 
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(para)); 127.2 (d, 2 arom. CH (ortho)); 51.2 (q, MeO); 37.3 (q, MeN); 35.6 (d, CH); 
31.6, 29.1 (2t, 2 CH2); 17.9 (q, Me). CI-MS (NH3):  251 (15), 250 (100, [M + 1]
+). 
Anal. calc. for C14H19NO3 (249.31): C 67.45, H 7.68, N 5.62; found: C 67.22, H 7.93, N 
5.54. 
2.5. Methyl 4-methyl-5-(N-methyl-N-phenylamino)-5-thioxopentanoate (16). To a 
soln. of 15 (2.599 g, 10.43 mmol) in toluene (10 ml), Lawesson reagent (2.57 g, 6.35 
mmol, 1.2 equiv.) was added, and the mixture stirred for 30 min at 130°. The excess of 
Lawesson reagent was precipitated with Et2O, the precipitate filtered over Celite, and 
the filtrate evaporated. CC (hexane/AcOEt 4 : 1) yielded 2.564 g (93%) of 16 as a pale 
brown oil. Rf (hexane/AcOEt 4 : 1) 0.18. IR (neat): 2969m, 2930m, 2868w, 1737s, 
1595m, 1493s, 1444s, 1385s, 1332m, 1269m, 1198s, 1112m, 1074w, 1037m, 1002m, 
919w, 877w, 853w, 834w, 774m, 702s. 1H-NMR: 7.5 – 7.35 (m, 3 arom. H (meta, 
para)); 7.15 – 7.1 (m, 2 arom. H (ortho)): 3.71, 3.58 (2s, MeO, MeN); 2.8 – 2.7 (m, 
CH); 2.3 – 2.1 (m, 3 H of 2 CH2); 1.8 – 1.55 (m, 1 H of 2 CH2); 1.32 (d, J = 6.6, Me). 
13C-NMR: 210.6 (s, CS); 173.3 (s, CO); 145.4 (s, 1 arom. C); 129.9, 128.4, 125.6 ( 3d, 5 
arom. CH); 51.3 (q, MeO); 45.5 (q, MeN); 42.8 (d, CH); 32.7, 31.7 (2t, 2 CH2); 22.0 (q, 
Me). CI-MS (NH3):  268 (6), 267 (16), 266 (100, [M + 1]
+). Anal. calc. for C14H19NO2S 
(265.37): C 63.36, H 7.22, N 5.28, S 12.08; found: C 63.34, H 7.20, N 5.28, S 12.11. 
2.6. Methyl 3-(3-Amino-N,2-dimethyl-N-phenyl-2H-azirin-2-yl)propanoate (10). 
To a soln. of 16 (2.558 g, 9.64 mmol) and 5 drops of abs. DMF in abs. CH2Cl2 (12 ml) 
at 0°, 2N phosgene in toluene (6.5 ml, ca. 13 mmol, 1.3 equiv.) was added slowly, the 
ice bath was removed, the mixturre stirred for 25 min, and the solvent evaporated. The 
residue was dissolved in abs. THF (12 ml), DABCO (1.096 g, 9.77 mmol) was added, 
and the soln. was stirred for 25 min at r.t. After filtration and addition of abs. DMF (12 
ml), NaN3 (1.256 g, 19.32 mmol, 2 equiv.) was added, the mixture stirred for 3 d at r.t. 
 12 
and then filtered over Celite, and the filtrate was evaporated. CC (hexane/AcOEt 2 : 1) 
yielded 2.143 g (90%) of 10 as a yellow oil. In the 1H-NMR- and 13C-NMR-spectra at 
270K and 280K, doubling of signals was observed, which almost disappeared at 300K, 
and showed EXSY cross peaks. Therefore, it is assumed that two conformers are 
detected at r.t. They were analyzed by HSQC and HMBC experiments at 270K. Rf 
(hexane/AcOEt 2 : 1) 0.10. IR (neat): 2950w, 2920w, 1749s, 1656w 1600s, 1502s, 
1438m, 1375w, 1347w, 1319w, 1300m, 1286m, 1228m, 1198m, 1161m, 1112m, 1086w, 
1071w, 1035w, 987w, 894w, 841w, 756m. 1H-NMR (600 MHz, 270 K): 7.60 (d, J = 8.1, 
2 arom. CH(ortho), minor conformer); 7.45 – 7.4 (m, 2 arom H(meta)); 7.2 – 7.1 (m, 1 
arom. H(para)); 7.05 (d, J = 7.9, 1 arom. H(ortho), major conformer); 3.54 (s, MeO, 
minor conformer);  3.53 (s, MeO, major conformer); 3.45 (s, MeN, major conformer);  
3.43 (s, MeN, minor conformer); 2.35 – 2.3 (m, 1 H of CH2CO, minor conformer); 2.3 – 
2.25 (m, 1 H of CH2CO, minor conformer, 1 H of CH2CO, major conformer, 1 H of 
CH2C(3), major conformer); 2.15 – 2.1 (m, CH2C(3), minor conformer, 1 H of CH2CO, 
major conformer); 2.05 – 2.0 (m, 1 H of CH2C(3), major conformer); 1.48 (s, Me, major 
conformer); 1.43 (s, Me, minor conformer). 13C-NMR (151 MHz, 270 K): 173.9 (s, CO, 
minor conformer); 173.6 (s, CO, major conformer); 166.0 (s, C(3), major conformer); 
164.9 (s, C(3), minor conformer); 142.1 (s, 1 arom. C, minor conformer); 142.1 (s, 1 
arom. C, major conformer); 129.6 (d, 2 arom. CH(meta), major conformer); 129.2 (d, 2 
arom. CH(meta), minor conformer); 123.2 (d, 1 arom. CH(para), minor conformer); 
123.1 (d, 1 arom. CH(para), major conformer); 116.7 (d, 2 arom. CH(ortho), minor 
conformer); 115.4 (d, 1 arom. CH(ortho), major conformer); 51.6 (q, MeO); 45.9 (s, 
C(2), major conformer); 37.7 (q, MeN, minor conformer); 37.1 (s, C(2), minor 
conformer); 33.5 (q, MeN, major conformer); 32.1 (d, CH2C(2), major conformer); 31.2 
(d, CH2C(2), minor conformer); 29.9 (d, CH2CO, major conformer); 29.8 (d, CH2CO, 
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minor conformer); 24.5 (q, Me, major conformer); 23.5 (q, Me, minor conformer). CI-
MS (NH3):  248 (16), 247 (100, [M + 1]
+). Anal. calc. for C14H18N2O2 (246.30): C 
68.27, H 7.37, N 11.37; found: C 67.99, H 7.17, N 10.99. 
3. Reactions of the α-Methylglutamate Synthon 10 with Thiobenzoic Acid and Z-
L-Valine. 3.1. With Thiobenzoic Acid. Methyl 4-Methyl-5-(N-methyl-N-phenylamino)-4-
[(phenylcarbonyl)amino]-5-thioxopentanoate (17). To thiobenzoic acid (110 mg, 0.8 
mmol), a soln. of 10 (182 mg, 0.74 mmol) in abs. CH2Cl2 (5 ml) was added, and the 
mixture was stirred for 1 h at r.t. Prep. TLC (hexane/AcOEt 1 : 1) gave 281 mg (99%) 
of 17. Pale yellow crystals. M.p. 133.9 – 134.9°. Rf (hexane/AcOEt 2 : 1) 0.18. IR 
(KBr): 3444m, 3246m, 3065m, 3004m, 2956m, 2924m, 2853w, 1732s, 1641s, 1601m, 
1578m, 1548s, 1490s, 1463s, 1442m, 1363s, 1330m, 1294s, 1254m, 1219m, 1196m, 
1177m, 1093s, 1026w, 1006m, 980m, 934w, 898w, 857w, 803w, 773m, 706s. 1H-NMR: 
8.78 (br. s, NH); 7.8 – 7.75, 7.5 – 7.35 (2m, 10 arom. H); 3.76, 3.62 (2s, MeO, MeN); 
2.95 – 2.9 (m, 1 H of 2 CH2); 2.4 – 2.35 (m, 2 H of 2 CH2); 2.3 – 2.2 (m, 1 H of 2 CH2); 
1.68 (s, Me). 13C-NMR: 206.8 (s, CS); 173.8 (s, CO(ester)); 164.6 (s, CO(amide)); ca. 
147 (s, 1 arom. CN); 135.1 (s, 1 arom. C); 131.2, 129.5, 128.6, 128.3, 126.9, 126.5 (6d, 
10 arom. CH); 65.0 (s, C(4)); 51.6 (q, MeO); the signal for MeN was not observed; 
32.3, 29.3 (2t, 2 CH2); 26.0 (q, Me). ESI-MS (MeOH, NaI): 407 (100, [M + Na]
+). 
Anal. calc. for C21H24N2O3S (384.49): C 65.60, H 6.29, N 7.29, S 8.34; found: C 65.57, 
H 6.38, N 6.62, S 8.13. 
3.2. With Z-L-Valine. Methyl (RS)-4-({(S)-2-[(Benzyloxycarbonyl)amino]-3-
methyl-1-oxobutyl}amino)-4-methyl-5-(N-methyl-N-phenylamino)-5-oxopentanoate 
(18). A soln. of 10 (1.03 g, 4.18 mmol) and Z-L-valine (1.11 g, 4.42 mmol) in CH2Cl2 
(20 ml) was stirred at r.t. for 24 h, and evaporated. CC (CH2Cl2/MeOH 50 : 1) yielded 
1.99 g (96%) of 18. Colorless foam. M.p. 103 – 104°. Rf (CH2Cl2/MeOH 50 : 1) 0.16. 
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IR (KBr): 3337m, 2963m, 1733s, 1672s, 1633s, 1594m, 1495s, 1454m, 1371m, 1233m, 
1110m, 1026m, 774w, 703m. 1H-NMR: 7.46 (br. s, NH of Glu(2Me), diastereoisomer 
B); 7.45 – 7.25 (m, 10 arom. H); 7.16 (br. s, NH of Glu(2Me), diastereoisomer A); 5.4 – 
5.3 (m, NH of Val); 5.2 – 5.1 (m, PhCH2O); 4.0 – 3.9 (m, CH(2) of Val, B); 3.9 – 3.8 
(m, CH(2) of Val, A); 3.65 (s, MeO, B); 3.64 (s, MeO, A); 3.27 (s, MeN, B); 3.26 (s, 
MeN, A); 2.7 – 2.45 (m, 1 H of 2 CH2); 2.45 – 2.15 (m, 2 H of 2 CH2); 2.15 – 2.0 (m, 
CH(3) of Val); 1.95 – 1.8 (m, 1 H of 2 CH2); 1.42 (s, Me(3) of Glu(2Me), A); 1.38 (s, 
Me(3) of Glu(2Me), B); 0.95 – 0.85 (m, 2 Me(4) of Val). 13C-NMR: 173.4, 171.9, 
171.6, 169.2 (4s, CO(ester), 2 CO(amide)); 156.1 (s, CO(urethane)); 143.6, 143.4, 136.4 
(3s, 2 arom. C); 129.5, 128.6, 128.4, 128.4, 128.0, 127.9 (6d, 10 arom. CH); 66.8 (t, 
PhCH2O); 61.8, 61.5 (2s, C(2) of Glu(2Me)); 60.5, 60.2 (2d, CH(2) of Val); 51.6, 51.5 
(2q, MeO); 41.7, 41.6 (2q, MeN); 31.5, 30.8, 29.4, 29.2 (4t, 2 CH2 of Glu(2Me)); 31.4, 
31.3 (2d, CH(3) of Val); 23.2, 19.1, 19.0, 17.5, 17.2 (5q, Me(3) of Glu(2Me), 2 Me of 
Val). ESI-MS (MeOH, NaI): 520 (100, [M + Na]+). Anal. calc. for C27H35N3O6 
(497.58): C 65.17, H 7.09, N 8.44; found: C 65.06, H 7.15, N 8.51. 
4. Deprotection of Dipeptide 18. 4.1. Cleavage of the Z Group.  Methyl (RS)-4-
[((S)-2-Amino-3-methyl-1-oxobutyl)amino]-4-methyl-5-(N-methyl-N-phenylamino)-5-
oxopentanoate (19). A soln. of dipeptide 18 (200 mg, 0.402 mmol) and a small amount 
of Pd/C (10% on activated charcoal) in MeOH (10 ml) was treated with H2 for 2.5 h at 
r.t. The mixture was filtered over Celite, and the filtrate was evaporated. Prep. TLC 
(CH2Cl2/MeOH 20 : 1) gave 147 mg (quant.) of 19. Colorless, highly viscous substance. 
Rf (CH2Cl2/MeOH 10 : 1) 0.25. IR (neat): 3322m, 2959s, 2874m, 1737s, 1638s, 1594m, 
1495s, 1452m, 1368m, 1271m, 1222m, 1200s, 1174s, 1110m, 1082w, 1033w, 995w, 
852w, 777w, 735w, 706m. 1H-NMR: 8.15, 7.80 (2 br. s, NH of Glu(2Me)); 7.45 – 7.3 
(m, 5 arom. H); 3.68, 3.65 (2s, MeO); 3.28, 3.26 (2s, MeN); 3.11, 3.01 (2d, J = 4.1 and 
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3.8, resp., CH(2) of Val); 2.7 – 2.0 (m, 2 CH2, CH(3) of Val); 1.95 – 1.9 (m, NH2 of 
Val); 1.48, 1.39 (2s, Me(3) of Glu(2Me)); 0.96, 0.93, 0.83, 0.79 (4d, J = 7.0, 7.0, 6.9, 
and 6.9, resp., 2 Me(4) of Val). 13C-NMR: 173.5, 173.3, 172.4, 172.2, 171.6 (5s, 3 CO); 
144.5, 144.1 (2s, arom. C); 129.4, 129.3, 128.1, 128.0, 127.8, 127.7 (6d, 5 arom. CH); 
60.9 (s, C(2) of Glu(2Me)); 60.3, 60.3 (2d, CH(2) of Val); 51.6, 51.5 (2q, MeO); 41.6, 
41.5 (2q, MeN); 32.9, 31.4 (2t, CH2); 30.8 (d, CH(3) of Val); 29.4, 29.1 (2t, CH2); 23.7, 
23.3, 19.5, 19.4, 16.3 (5q, Me(3) of Glu(2Me), 2 Me(4) of Val). ESI-MS (MeOH): 749 
(23, [2M + Na]+), 727 (40, [2M + 1]+), 402 (17, [M + K]+), 386 (100, [M + Na]+), 364 
(46, [M + 1]+), 257 (24, [M – N(Me)Ph]+). 
4.2. Hydrolysis of the Amide Group. 4.2.1. Methyl 3-(2-{(S)-1-[(Benzyloxycarbo-
nyl)amino]-2-methylpropyl}-(RS)-4-methyl-5-oxo-1,3-oxazol-4-yl)propanoate (23). A 
soln. of dipeptide 18 (301 mg, 0.605 mmol) in toluene (60 ml) was heated to 105°. For 
13 min, HCl (g) was bubbled through the mixture. During this procedure, the 
temperature fell to 90 – 95°. The remaining HCl (g) was removed by bubbling N2 
through the soln. for 20 min. The mixture was transferred into another flask with 
hexane, and crystals of N-methylanilide chloride precipitated, were filtered (55mg, 0.39 
mmol, 64%), and the resulting soln. was evaporated. CC (hexane/AcOEt 2 : 1) yielded 
182 mg of 23, which still contained some AcOEt, and 67 mg of starting material 18 
(22%). Calculation of the yield based on NMR integrals gave 168 mg 23 (71%) and 14 
mg AcOEt. This material was hydrolized to the corresponding acid. For analytical 
purposes, 23 was dried in HV. Rf (hexane/AcOEt 2 : 1) 0.17. IR (neat): 3338m, 3066w, 
3035w, 2966s, 2936m, 2877w, 1823s, 1732s, 1673s, 1526s, 1453m, 1375m, 1311s, 
1233s, 1177s, 1146m, 1027m, 966m, 897s, 775w, 740w, 699m. 1H-NMR: 7.35 – 7.3 (m, 
5 arom. H); 5.35 – 5.25 (m, NH of Val); 5.15 – 5.1 (m, PhCH2O); 4.55 – 4.45 (m, CH(2) 
of Val); 3.65, 3.63 (2s, MeO); 2.4 – 2.05 (m, CH(3) of Val, 2 CH2 of Glu(2Me)); 1.40 
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(br. s, Me(3) of Glu(2Me)); 1.02, 0.98, 0.95 (3d, J = 6.8, 6.9, and 6.9, resp., 2 Me(4) of 
Val). 13C-NMR: 179.5 (s, C(5)); 172.3 (s, CO(ester)); 163.0 (s, C(2)); ca. 156 (s, 
CO(urethane)); 136.0 (s, 1 arom. C); 128.4, 128.1, 128.0 (3d, 5 arom. CH); 67.6 (s, 
C(4)); 67.1 (t, PhCH2O); 55.2, 54.7 (2d, CH(2) of Val); 51.6 (q, MeO); 32.3 (t, CH2); 
30.7, 30.5 (2d, CH(3) of Val); 28.6 (t, CH2); 23.5, 23.3, 18.8, 18.8, 17.5, 17.1 (6q, 
Me(3) of Glu(2Me), 2 Me(4) of Val). ESI-MS (MeOH, NaI): 413 (100, [M + Na]+). 
Anal. calc. for C20H26N2O6 (390.44): C 61.53, H 6.71, N 7.17; found: C 61.78, H 6.80, 
N 7.04. 
4.2.2. (RS)-2-({(S)-2-[(Benzyloxycarbonyl)amino]-3-methyl-1-oxobutyl}amino)-
5-methoxy-2-methyl-5-oxopentanoic Acid (21). 4.2.2.1. Procedure A. From oxazolone 
23. A suspension of 158 mg of crude 23 (containing AcOEt, i.e. 146 mg, 0.374 mmol of 
23) in 2 ml H2O was stirred for 18 h at r.t., 2 ml of THF were added, and the suspension 
was stirred for 4 h at r.t. and for 1 h at 50°. As no hydrolysis was observed, one drop of 
6N HCl was added. After stirring at 50° for 2 h, the hydrolysis was complete. Brine was 
added, and the soln. was extracted 3 × with AcOEt. The combined org. layers were 
dried (MgSO4) and evaporated: 161 mg (quant.) of crude 21. After Prep. TLC 
(CH2Cl2/MeOH 10 : 1), 109 mg (71%) of pure 21 were obtained as a colorless foam. 
4.2.2.2. Procedure B. From amide 18. A soln. of 18 (152 mg, 0.305 mmol) in 
toluene (30 ml) was heated to 110°. For 20 min, HCl (g) was bubbled through the 
mixture. During this procedure, the temperature fell to 100 – 95°. The remaining HCl 
(g) was removed by bubbling N2 through the soln. for 20 min. The mixture was 
transfered into another flask with hexane, and crystals of N-methylanilide chloride 
precipitated, were filtered, and the resulting soln. was evaporated. This crude material 
was solved in 2 ml of THF and 2 ml of H2O, and 1 drop of 6N HCl was added. After 
stirring at 50° for 2.5 h, the hydrolysis was complete. Brine was added, and the soln. 
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was extracted 3 × with AcOEt. The combined org. layers were dried (MgSO4), and 
evaporated. Prep. TLC (CH2Cl2/MeOH 10 : 1) gave 87 mg (70%) of pure 21, and a 
mixture of 23 mg (15%) of starting material 18 and 18 mg (12%) of oxazolone 23 (ratio 
determined by NMR). 
4.2.2.3. Procedure C. Under standard conditions from amide 18. A soln. of 18 
(152 mg, 0.305 mmol) in 3N HCl (THF/H2O 1 : 1, 5 ml) was stirred for 1 h at r.t. The 
mixture was extracted with CH2Cl2, dried (MgSO4), and evaporated. Prep. TLC 
(CH2Cl2/MeOH 10 : 1) yielded 81 mg (40%) of starting material 18, and a mixture of 
53 mg (27%) of 20 and 23 mg (14%) of 21 (ratio determined by NMR). 
Data of 21. M.p. 60-62°. 1H-NMR: ca. 8.9 (br., COOH); ca. 7.4 (br. s, NH of 
Glu(2Me)); 7.35 – 7.25 (m, 5 arom. H); 5.79 (d, J = 8.6, NH of Val); 5.11 (s, PhCH2O); 
4.15 – 4.1 (m, CH(2) of Val); 3.64, 3.62 (2s, MeO); 2.55 – 2.0 (m, CH(3) of Val, 2 CH2 
of Glu(2Me)); 1.59 (s, Me(3) of Glu(2Me)); 1.0 – 0.9 (m, 2 Me(4) of Val). 13C-NMR: 
ca. 176, ca. 174, 171.5 (3s, CO(acid), CO(ester), CO(amide)); ca. 157 (s, 
CO(urethane)); ca. 135 (s, 1 arom. C); 128.5, 128.2, 128.0 (3d, 5 arom. CH); 67.2 (t, 
PhCH2O); 60.6 (d, CH(2) of Val); 60.0 (s, C(2) of Glu(2Me)); 52.0 (q, MeO); 31.4 (t, 1 
CH2); 31.0 (d, CH(3) of Val); 29.3 (t, 1 CH2); 22.9, 19.3, 19.1 (3q, Me(3) of Glu(2Me), 
2 Me(4) of Val). ESI-MS (MeOH): 447 (8, [M + K]+), 432 (23), 431 (100, [M + Na]+).  
Anal. calc. for C20H28N2O7·0.2 H2O (412.05): C 58.30, H 6.95, N 6.80; found: C 58.26, 
H 6.95, N 6.69. 
4.3. Hydrolysis of the Ester Group. 4.1.1. (RS)-4-({(S)-2-[(Benzyloxycarbonyl)-
amino]-3-methyl-1-oxobutyl}amino)-4-methyl-5-(N-methyl-N-phenylamino)-5-oxopen-
tanoic Acid (20). To a soln. of 20 (213 mg, 0.428 mmol) in 6 ml of a 3 : 1 : 1 mixture of 
THF, MeOH, and H2O, LiOH⋅H2O (54.5 mg, 1.30 mmol, 3 equiv.) was added. The 
mixture was stirred at r.t. for 2 h, and then neutralized with 6N HCl. The aqueous layer 
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was extracted with CH2Cl2, and the combined org. layers were washed with 1N HCl, 
dried (MgSO4), and evaporated: 213 mg (quant.) of 20. Colorless solid. M.p. 80 – 81°. 
Rf (CH2Cl2/MeOH 10 : 1) 0.31. IR (KBr): 3422s (broad), 3065m, 2965m, 2929m, 1717s, 
1633s, 1593m, 1495s, 1455m, 1388m, 1261m, 1236m, 1110m, 1085m, 1028m, 801w, 
774w, 738w, 701m. 1H-NMR: 7.55 (br. s, NH of Glu(2Me)); 7.4 – 7.2 (m, 10 arom. H); 
5.7 – 5.6 (m, NH of Val); 5.15 – 5.1 (m, PhCH2O); 3.95 – 3.85 (m, CH(2) of Val); 3.27, 
3.24 (2s, MeN); 2.7 – 1.8 (m, CH(3) of Val, 2 CH2 of Glu(2Me)); 1.43, 1.39 (2s, Me(3) 
of Glu(2Me)); 0.95 – 0.85 (m, 2 Me(4) of Val). 13C-NMR: 176.4, ca. 172, ca. 171, 
169.8 (4s, CO(acid), 2CO(amide)); 156.6, 156.5 (2s, CO(urethane)); 143.4, 136.2 (2s, 2 
arom. C); 129.6, 129.4, 128.4, 128.1, 128.0 (5d, 10 arom. CH); 67.0 (t, PhCH2O); 61.9, 
61.2 (2s, C(2) of Glu(2Me)); 60.8, 60.2 (2d, CH(2) of Val); 41.7, 41.5 (2q, MeN); 31.4, 
31.1 (2d, CH(3) of Val); 29.4, 28.9 (2t, 2 CH2 of Glu(2Me)); 23.2, 23.1, 19.1, 17.7, 17.5 
(5q, Me(3) of Glu(2Me), 2 Me(4) of Val). CI-MS (NH3): 484 (12, [M + 1]
+), 466 (9, [M 
– OH]+), 395 (8), 394 (38, [M – Benzyl + 2]+), 378 (10), 377 (45, [M – NMePh]+), 376 
(8), 125 (8), 109 (8), 108 (100, PhCH2OH
+·). Anal. calc. for C26H33N3O6·0.5 H2O 
(501.58): C 63.40, H 6.96, N 8.53; found: C 63.33, H 6.79, N 8.29. 
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2 : 2 : 3
CH2N2, THF
Lawesson reagent
Toluene, 120°
1. LDA, THF, 0°
2. DPPCl, THF, 0° - r.t.
3. NaN3, THF/DMF, r.t.
1. COCl2, Toluene
    CH2Cl2, DMF, 0°
2. DABCO, THF, r.t.
3. NaN3, DMF, r.t.
Scheme 1
LDA = lithium diisopropylamide; DMI = 1,3-dimethylimidazolidin-2-one;
DPPCl = diphenylphosphorochloridate; DABCO = 1,4-diazabicyclo[2.2.2]-octane  
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